Rebecca Spalding
Reuters has hired Bloomberg News reporter Rebecca Spalding to cover mergers and acquisitions in health care, biopharmaceuticals and industrial industries.
She will be based out of New York.
“Thank you all for your kind words in the last few days! It’s a great team and I’m excited for the new challenge,” she wrote on Twitter.
Spalding was based on Boston for Bloomberg. She has written about a drug with a $2 million price tag, a Harvard professor who made $400 million in an biotechnology IPO, Blackstone’s foray into drug development, and how Cambridge, Massachusetts, came to be a magnet for the industry.
She had been at Bloomberg for nearly four years and had previously interned at Forbes.
PCWorld executive editor Gordon Mah Ung, a tireless journalist we once described as a founding father…
CNBC senior vice president Dan Colarusso sent out the following on Monday: Before this year comes to…
Business Insider editor in chief Jamie Heller sent out the following on Monday: I'm excited to share…
Former CoinDesk editorial staffer Michael McSweeney writes about the recent happenings at the cryptocurrency news site, where…
Manas Pratap Singh, finance editor for LinkedIn News Europe, has left for a new opportunity…
Washington Post executive editor Matt Murray sent out the following on Friday: Dear All, Over the last…
View Comments
You need to look into KKRs Covenant Physician Partners entity with respect to their performance vis a vis the physicians. Also examine the debt structure.